Search results
Order by most recent / most popular / relevance
Results: 1-10 of 16
Valeant divests three drugs in order to complete acquisition of certain dermatology assets from Sanofi and J&J
- Hogan Lovells
- -
- USA
- -
- June 12 2012
In July 2011, Valeant announced that it had entered into agreements with divisions of Sanofi and Johnson & Johnson (J&J) to acquire certain dermatology assets from each
FTC consent order settles charges that Inverness Medical Innovations monopolized consumer pregnancy test market
- Hogan Lovells
- -
- USA
- -
- March 29 2009
On December 23, 2008, the Federal Trade Commission (FTC) announced a consent order settling charges that Inverness Medical Innovations, Inc. (Inverness) unlawfully maintained monopoly power in the consumer pregnancy test market when it acquired certain assets of rival ACON Laboratories, Inc., (ACON) in 2006
FTC carves out laser microdissection device in DanaherMDS merger
- Hogan Lovells
- -
- USA
- -
- March 11 2010
Danaher Corporation executed a stock purchase agreement valued at $650 million with MDS, Inc., through which Danaher would acquire MDS, inclusive of its Arcturus Life Sciences Business, in September 2009
Commissioner Rosch delivers speech on continued enforcement efforts in pharmaceutical sector
- Hogan Lovells
- -
- USA
- -
- March 11 2010
On Februrary 18, 2010, Commissioner Thomas Rosch delivered a speech to the In-House Counsel Forum on Pharmaceutical Antitrust
FTC clears Teva-Barr combination with divestitures
- Hogan Lovells
- -
- USA
- -
- March 29 2009
On February 10, 2009, the FTC cleared Teva Pharmaceutical Industries’ acquisition of Barr Pharmaceuticals with divestitures
FTC consent order requires divestiture of painkiller Kadian in KingAlpharma merger
- Hogan Lovells
- -
- USA
- -
- March 29 2009
On December 29, 2008, the Federal Trade Commission (FTC) announced a consent order allowing King Pharmaceuticals, Inc, to acquire rival drug-maker Alpharma Inc
FTC seeks divestiture and disgorgement of profits in price-gouging lawsuit against Ovation
- Hogan Lovells
- -
- USA
- -
- March 29 2009
On December 16, 2008, the Federal Trade Commission (FTC) filed a complaint in the U.S. District Court for the District of Minnesota challenging Ovation Pharmaceuticals’ acquisition of NeoProfen, a drug used to treat a potentially deadly congenital heart defect affecting more than 30,000 babies born prematurely in the U.S. each year
FTC orders post-consummation divestiture of outpatient clinics
- Hogan Lovells
- -
- USA
- -
- November 23 2009
In July 2009, the FTC filed an administrative complaint against Carilion Clinic for its 2008 acquisition of an outpatient imaging center, the Center for Advanced Imaging (CAI),and an outpatient surgical center, the Center for Surgical Excellence (CSE), in Roanoke, Virginia
Antitrust challenges to citizens' petitions required to demonstrate delay of ANDA approval
- Hogan Lovells
- -
- USA
- -
- July 30 2009
In two recent cases involving antitrust claims against branded manufacturers for alleged attempts to delay and prevent generic entry, plaintiffs alleged that each branded manufacturer filed a frivolous citizen petition with the U.S. Food and Drug Administration (FDA), which delayed FDA approval of generic products
FTC is given go-ahead in suit against Ovation
- Hogan Lovells
- -
- USA
- -
- July 30 2009
In Federal Trade Commission v. Lundbeck, Inc., Civ. No. 08-6379 (D. Minn. 2009), a district court judge denied Lundbeck’s, formerly Ovation Pharmaceuticals, Inc.’s, motions for summary judgment
Current Search
- Workarea - Healthcare
- Author - Leigh L. Oliver
Suggested Facets
Author
- Corey W. Roush (1)
- Eric Stock (1)
- Lauren E. Battaglia (1)
- Robert F. Leibenluft (1)
- William H. Rawson (1)